Most Read Articles
Stephen Padilla, 3 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

6 days ago
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.

Opportunities for improvement shown for pharmacists dealing with patients on oral chemotherapy

03 Oct 2019

A recent study has underscored ways for pharmacists to improve treatment of patients newly initiated on oral chemotherapy.

“Opportunities exist to increase patient education, ensure appropriate follow-up and assess adherence while preventing and managing treatment-related toxicities,” the investigators said.

A total of 100 patient charts in an outpatient cancer centre were reviewed. Median time to oral chemotherapy receipt by the patient from the day the order was given was 8 days. Of the patients, 27 percent received education from a clinical pharmacist before treatment initiation.

The provider carried out toxicity checks at 30, 60 and 90 days for 80 percent, 65 percent and 48 percent of patients, respectively. Seventy-nine percent of patients reported treatment-related toxicities secondary to oral chemotherapy, of which 55 percent were classified as severe. Potential drug interactions presented in 55 percent of the patients.

This single-centre, retrospective chart review was conducted to estimate the prevalence of drug-related problems among patients treated with oral chemotherapy agents. Those prescribed oral chemotherapy between 1 January 2017 and 31 August 2017 were included.

The incidence of drug-related toxicities within 90 days of treatment initiation was the primary endpoint, while secondary endpoint included incidence of drug–drug interactions, proportion of patients receiving medication education by a clinical pharmacist and quantification of issues related to medication access.

“Although oral chemotherapy offers advantages over intravenous chemotherapy, it creates a unique set of challenges,” the investigators noted. “Potential barriers include treatment complexity, patient responsibility for medication adherence and monitoring, reduced healthcare contact, and increased financial burden.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 3 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

6 days ago
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.